ABSTRACT-Sepsis accounts for a huge number of deaths in intensive care units worldwide. Encouraging data from recent studies show that some interventions are able to reverse such a picture. Surviving Sepsis Campaign (SSC) bundles were built based on these interventions. Many studies were published analyzing the impact of sepsis protocol implementation on compliance, costs, and mortality, and the results are herein analyzed. Based on these studies, it is not clear if the reduction is secondary to improvement in the quality of care naturally associated with protocol implementation or to the improvement in compliance to strict goals. A high heterogeneity is present among institutions and countries, and the pitfalls for protocol implementation seem to depend on local characteristics. In the same way, the impact of interventions might be different according to each institution's epidemiological profile. Interventions not impacting in lowmortality-rate institutions can be important for places where mortality is high. In Brazil, mortality rates are very high, and the results of Brazilian SSC network are presented and discussed.
INTRODUCTION
The incidence of sepsis has increased dramatically in the past decades. Several factors have possibly played a role in such an increase, as advanced age, increased diagnostic and therapeutic procedures, frequent use of immunosuppressive drugs, and the growing number of multiresistant bacterial infections, especially within the nosocomial environment (1) . A study has projected 750,000 cases of severe sepsis for 2001 in the United States (with about 210,000 deaths), with a 1.5% yearly growth (2) ; whereas in Brazil, these figures may reach 500,000 cases yearly (3, 4) .
Sepsis has a high mortality rate, with literature reports ranging between 19.6% and 59.0% (5) . In Brazil, mortality rates are also very high. The first Brazilian multicenter observational epidemiological trial, BASES, has shown incidence rates for sepsis, severe sepsis, and septic shock of 61. 4, 35.6 , and 30 per 1,000 patients-day, respectively. The mortality rate has progressively grown as the diagnosis progressed from systemic inflammatory response syndrome to sepsis, severe sepsis, or septic shock (24.3% to 34.7%, 47.3%, and 52.2%, respectively) (3) . The data from the Sepse Brasil trial, conducted in 75 intensive care units (ICUs), have shown that 17% of intensive care beds are taken by these patients, and that the mortality rate has a close relationship with progression from sepsis to severe sepsis and septic shock, with 16.7%, 34.4%, and 65.3%, respectively (6) . The COSTS trial confirmed this high mortality rate (7) .
A clear mortality difference between other countries and Brazil was again shown in the PROGRESS trial. In 12,570 patients, the mean ICU mortality was 39.2%, with relevant differences between countries. In Brazil, the ICU mortality was 56.1%, only comparable to that of Malaysia (56.8%) and much higher than other countries' mortality (Germany, 36.3%; Argentina, 46.6%; Canada, 30.3%; India, 37.4%; United States, 33.0%; and Australia, 22.0%) (8) .
The social and economic burden associated with the disease is concerning (9) . According to North American data, about U$22,000 per patient are spent, a figure that might be higher for intensive care patients (2) . A Brazilian study found a mean U$ 9,632 cost per patient during ICU stay (7) . Moreover, severe sepsis and septic shock survivors were described as showing late mortality rate and a significant drop in their health-related quality of life (10) .
Encouraging data from recent studies have shown that it is possible to reverse this picture. However, incorporating new evidence into medical practice is a slow process. The Surviving Sepsis Campaign (SSC), sponsored by the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, and the International Sepsis Forum, is an effort to change the standard of care in sepsis management based on the published data available (11) . Despite some controversies (12) , severe sepsis bundles account for the core of the SSC implementation phase.
More recently, some authors evaluated the impact of sepsis protocol implementation, based on the Campaign, on these patients' mortality and costs. These studies will be herein analyzed, as well as the recent worldwide SSC data.
SEPSIS MORTALITY RATES: IS IT POSSIBLE TO REDUCE THEM?
Gao et al. (13) were the first to show that complying with the 6-h bundles items resulted in significant mortality reduction in a small group of patients (49% vs. 23%; relative risk, 2.12 [1.20Y3.76]; P = 0.01).
Later, other trials pointed to the same direction. In a beforeand-after trial, it was shown that the protocol implementation led to more appropriate volume replacement and antibiotic treatment, resulting in significant hospital length of stay and mortality reduction (48.3% vs. 30.0%, P = 0.04) (14) . With this design, it was also possible to show in a 2,319 patient series in Spain a significant mortality reduction (44.0% vs. 39.7%) associated with improved compliance with the Campaign bundles (15) . Interestingly, the mortality reduction remained stable even 1 year after the trial, showing that the accrued results may be perennial, despite the trend toward compliance reduction. This suggests that protocol implementation leads to changes in internal processes and in the health team's way of thinking. So, although the strict SSC targets may have not been achieved by the study end, the improvement in processes was undisputable, and leads to a long-lasting mortality reduction.
Nguyen et al. (16) have also shown that the resuscitation bundles compliance was associated with significant hospital mortality reduction (39.5% vs. 20.8%, P G 0.01). Other smaller trials have confirmed these findings, with relative mortality reductions ranging between 20% and 55% (17Y20), including in the elderly patient population (21) . In this specific patient group, an increase in the amount of volume received and reduction of vasoactive drugs were also shown. Even in developing countries, it was possible to show the efficacy of these measures, with a trial showing a mortality reduction from 72.7% to 48.5%, although in a small series (22) .
One of the trials showed not only mortality (70.0% to 51.7%) and hospital length of stay reduction (in average 5 days less), but also a significant cost reduction (U$ 21,985 to U$16,103; P = 0.008) (23) . On the other hand, a trial showed that there is a cost increase. However, protocol implantation was cost-effective, with unequivocal gains in quality-of-lifeadjusted survival (24) .
Despite these promising results, a few trials failed to show mortality reduction (25Y28). Some authors correctly noted that although compliance with treatment guidelines was shown, the limited number of cases had no sufficient power to allow this kind of evaluation (25) . Yet, others effectively discuss the bundles effectiveness, highlighting that their sites mortality was small even before the protocol implementation (26, 27) . It should, however, be highlighted that a publication bias is very likely, as the negative trials tend not to be published.
WHAT REALLY MATTERS: PROCESS IMPROVEMENT OR STRICT COMPLIANCE?
It is not clear if bundles implementation would lead to improved survival because of the real impact of their diagnostic/ therapeutic measures or if this survival just comes from the educational process involved in the protocol implementation. In other words, is strict bundles compliance responsible for the reduced mortality or deaths are equally reduced in compliant or noncompliant patients just from the improved processes, including early sepsis detection? It is very likely that adopting protocols, even with no rigid targets, can entail improved survival. This was, e.g., clearly shown by Lin et al. (19) in a randomized early goal-directed therapy trial without venous oxygen saturation use. These authors have shown that just using central venous pressure (CVP), arterial pressure, and diuresis as treatment targets has an impact on mortality.
The analysis of a bundles application is not simple. It is very difficult testing appropriately the entire bundles effectiveness because the efficacy of each component alone may be variable. In addition, an interaction may exist between one and another measure, and the association effect may be different from the predicted synergism. Equally proving a given bundles effectiveness does not mean that all of its items have effectively contributed to reduced mortality. It has been shown that mortality reduction follows the improvement in indicators compliance, but a causal relationship between these is not easily shown. Most articles choose a before-and-after design, where reduced postintervention mortality is found, and the relationship between adequate treatment and mortality, both in pre-and postintervention patient groups, is not approached (15, 17, 20, 21, 25, 29) . Nevertheless, some observational studies tried to correlate, in univariate or multivariate analysis, bundles compliance and survival.
Zambon et al. (18) have identified that compliance to all 6-h bundles items was related to improved survival and shorter hospital length of stay, even in a small 61-patient series. Yet, the 24-h bundles compliance did not correlate with any of these outcomes. No specific analysis was conducted for each bundles item, possibly because of the small sample size (18). Nguyen et al. (16) used modified 6-h bundlesYbased protocol in 330 patients admitted from the emergency department and showed improvement in all indicators in the 12 months after the protocol implementation. Although in the univariate analysis all of them were correlated with improved mortality, in the multivariate analysis, only compliance to hemodynamic optimization was related to improvement.
Girardis et al. (30) have recently shown that compliance to all 6-and 24-h bundles items was associated with reduced mortality in a small group of patients (n = 86). Interestingly, they showed that compliant patients differ from noncompliant patients regarding their Simplified Acute Physiology score. This is a relevant observation because more severe patients could have more difficulty to reach the proposed targets and, thus, would more likely be in the noncompliant group, falsely increasing this group's mortality. However, the actual mortality for the compliant group was lower than the predicted, whereas in the noncompliant group, it was higher. In addition, the multivariate analysis has shown an association between survival and compliance to all 6-and 24-h bundles items.
Micek et al. (14) , although focusing their trial in the beforeand-after protocol comparison, analyzed some aspects regarding the association between compliance and mortality in a 120Ysepsis patient cohort. They showed, in a multivariate analysis, increased mortality among the patients not receiving 20 mL/kg volume before vasopressor (odds ratio [OR], j2.66 [1.67Y4.24]; P = 0.036). However, there was no association between appropriate antibiotic therapy and survival.
An important systematic literature review was recently published aiming to analyze the relationship between protocol implementation and clinical outcome (31) . This review analyzed eight nonblind trials: one randomized and seven with historic controls. It should be emphasized that some important trials were not included in this analysis (15, 18, 24, 29) . This systematic review has shown that protocols implementation leads to improved indicators performance. Thus, the time to antibiotic treatment administration and its appropriateness were significantly better in the intervention group as compared with the controls. An important heterogeneity was found regarding other measures such as volume replacement, vasopressors, and inotropic agents, suggesting that these goals are not easily applicable. Fundamentally, the pooled data evaluation versus control groups has shown increased survival associated with treatment (OR, 1.91 [1.49Y2.45]; P = 0.0001), but no analysis was made regarding the impact of compliance on mortality. Thus, it was shown that the use of a protocol treatment improves the performance and reduces mortality in treated patients versus out-ofprotocol patients. Again, it was not analyzed if patients to whom the bundles were successfully applied had improved mortality.
The global SSC results were recently published (32) . This is the largest trial ever published on bundles compliance, including 15,020 patients in 166 hospitals from all continents. The data have shown significantly increased compliance to all isolated items and the 6-and 24-h bundles set. In addition, during the 2 years' campaign, a significant mortality reduction was identified, 5.4% (95% confidence interval [CI], 2.5%Y8.4%), with a 14.5% relative reduction. The mortality reduction chance has grown proportional to the time the hospital was involved in the campaign. It would be possible ascribing this mortality reduction to the natural improvement of patient care along the years. However, when the data were temporally analyzed, considering the calendar month and year of the patients' inclusion and not the months the hospital was in the campaign, this reduction was not shown.
One of the most relevant data shown was the association identified between mortality reduction and bundles compliance. Administration of broad-spectrum antibiotics (OR, 0.86; 95% CI, 0.79Y0.93; P G 0.0001), obtaining blood cultures before their initiation (OR, 0.76; 95% CI, 0.70Y0.83; P G 0.0001), and maintaining blood glucose control (OR, 0.67; 95% CI, 0.62Y0.71; P G 0.0001) were all associated with lower hospital mortality. In septic shock patients, administration of drotrecogin alfa in the first 24 h was associated with improved survival (OR, 0.81; 95% CI, 0.68Y0.96; P = 0.02), as well as achieving plateau pressure control on those under mechanical ventilation (OR, 0.70; 95% CI, 0.62Y0.78; P G 0.0001). However, no association between mortality and the use of low-dose steroids, the ability to achieve a CVP greater than 8 mmHg, measuring lactate or demonstration of ScvO 2 greater than 70% were found. This being the largest series ever reported, these findings should be valued because most of the previous trials had insufficient sample sizes to support this kind of analysis.
So, it seems that the main cause of successful protocols is the education process involved with it. However, compliance to some of the bundles items seems important, at least regarding antibiotic treatment administration and culture collection. Yet, the relevance of reaching strict hemodynamic targets is not this clearly shown in the literature.
WHAT ARE THE PITFALLS IN IMPLEMENTING SEPSIS PROTOCOLS?
The SSC data show a low compliance rate with several bundles items (32) . Other studies also show limitations for the protocols implementation process, even in developed countries, particularly regarding the use of a central venous catheter for CVP and venous oxygen saturation optimization (16) . Limitations are also pointed regarding the health care team qualification and infrastructure. There are natural difficulties in bundles implementation common to all countries, although with heterogeneous intensity. A more detailed SSC databank analysis may point to significant differences, including those regarding different approaches depending on the sepsis acquisition site. Literature reports show low compliance in the emergency setting (26) .
Regarding the recent SSC publication, it should be reminded that the initial campaign objective was a 25% mortality reduction within 5 years. The mortality reduction obtained in the first 2 years was statistically significant but fairly below the objective. Moreover, SSC is no longer recruiting patients in a worldwide basis, which means that data from other 3 years and long-lasting effects will not be available. This is also a heterogeneous case series, including developed, developing, and underdeveloped countries. It would be important to evaluate the results regionally. It is possible that important differences between countries or specific hospital groups are found in the compliance and mortality reduction profile.
These epidemiological understanding may result in differentiated strategies for each hospital category. As previously mentioned, in the recently published PROGRESS Trial, mortality has ranged significantly between different countries. Recently, the Australian group has shown that in 4,794 patients in the emergency department, only 50 complied with the EGDT inclusion criteria, and the mortality was very low among these patients (26%) (27) .
Bundles may have a different effect according to the population profile where the protocol is implemented. Thus, EGDT may not effectively reduce mortality in countries as Australia; however, its efficacy in underdeveloped countries cannot be extrapolated from currently available data because they probably do not reflect their reality. From this point, results of currently undergoing multicenter trials as EGDT should be carefully interpreted in developing or underdeveloped countries. The credibility of therapeutic measures as volume replacement and vasopressors should not be questioned by negative trials aiming at establishing the importance of central venous saturation optimization. In other words, skepticism may be highly harmful for these countries because simple measures as protocolized early volume resuscitation may have a large impact in a given hospital where mortality is 60% to 70% and no impact where it is 25%. It would be ideal conducting clinical trials in these countries; however, they usually lack the infrastructure needed for multicenter randomized trials.
BRAZILIAN SSC STATUS
As mentioned, Brazilian sepsis mortality is extremely high. The reasons for this finding are not yet fully understood, but delayed diagnosis and inappropriateness of initial treatment may have an important role. Latin American Sepsis Institute (ILAS) coordinates SSC in Brazil. In the last 4 years, ILAS has trained Brazilian public and private institutions on the Campaign guidelines implementation. Currently, the 3,200-patient database points to a worrisome situation, with mean mortality about 58.3%, similar to the previously described national trials, and definitely greater than the mean mortality of other Campaign participating countries (33.2%, n = 16,518) (4) . Even the mortality in potentially less severely ill patients, those admitted in the emergency department, or those with severe sepsis is very high (48.6% and 50.7%, respectively).
When only the 19 hospitals remaining in the Campaign for two consecutive years are analyzed (n = 2,135), a significantly improved compliance is found for all 6-and 24-h bundles indicators. However, no improvement was achieved in the full 6-h bundles implementation, with very low compliance levels (8.3%Y9.0%). This illustrates how hard optimization of an integrated care to sepsis patients can be. Concomitantly, a significant mortality reduction was seen between the first and third semesters (59.9% vs. 52.9%; P = 0.01; OR, j1.33 [1.04Y1.69]), with 7.0% absolute reduction and 11.6% relative reduction. Yet, when the first semester was compared with the last, this reduction was no longer seen. These results strongly suggest that one of the biggest challenges in Brazil is keeping the Campaign tonus. This is worrisome because the literature evidences indicate effectiveness and long-lasting results from sepsis protocols implementation. It is also possible that this lack of an effective and long-lasting mortality reduction, even with improved compliance, is associated with delayed diagnosis, with consequent delayed interventions in Brazil. Another possibility is that the improvement in compliance was not sufficiently high to result in improved outcomes. Moreover, global optimized care was not reached as demonstrated by the absence of increase in 6-h bundle compliance. A previous study did show that the time elapsed between installation of organ dysfunction and interventions can be quite long, and this is an important survival determinant in case of severe sepsis and septic shock (33) . A recent survey found that physicians caring for patients with sepsis recognize the difficulty of defining sepsis and are aware that they miss the diagnosis frequently (34) . Assunção and colleagues (35) , through 917 questionnaires completed in 21 Brazilian public, private, and university hospitals, with clinical questions about sepsis definitions, found that as few as 27.3% was able to identify a sepsis case and 56.7% a severe one.
As in trials analyzing different countries, Brazil has portrayed the same worldwide scenarios, with important heterogeneity. Even more concerning, the ILAS data confirm a significant mortality difference between public and private hospitals (65.0% and 53.2%, P = 0.0000, respectively). In Brazil, the public health system has important gaps, and the private health system is, overall, better rated. In the BASES trial, a significant mortality difference was identified between patients admitted to public (26.9%) and private hospitals (12.9%) (3). In the COSTS trial, now in patients admitted to 21 Brazilian ICUs, this difference was confirmed, showing respectively 49.1% and 36.7% mortality (P = 0.006) (7) . The biggest challenge for health care providers is implementing institutionally managed programs that take the best available scientific evidences to bedside. This process would ensure improved assistance practice. It is possible that this assistance practice is effectively different between public and private hospitals, mainly regarding managed protocols implementation.
CONCLUSIONS
Implementation of sepsis protocols leads to mortality reduction. It is not clear if this reduction is caused by the education process or if compliance to strict goals is important. Results all over the world are heterogeneous, and bundles implementation may have a different effect according to the population profile where the protocol is implemented.
Brazilian data showed a high mortality rate, and SSC bundles implementation was associated with a reduction, although this effect was not long lasting. It is also possible that in Brazil, this lack of an effective and long-lasting mortality reduction is associated with an absence of sufficient improvement of care and to delayed diagnosis, with consequent delayed intervention.
